Physician profile
James M Burke
NPI 1679670129
$2,602.33
in general payments reported to CMS, 2019-2025
32 companies · $23.38 in 2025
The $23.38 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,886 · 2020: $636 · 2021: $56.47 · 2025: $23.38.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $23.38.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $23.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Akcea Therapeutics, INC. | $628.13 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $359.47 | 2019-2020 | |
| Genzyme Corporation | $187.31 | 2019-2020 | |
| Csl Behring | $163.57 | 2019-2020 | |
| Emd Serono, INC. | $136.91 | 2019-2020 | |
| Avanir Pharmaceuticals, INC. | $106.09 | 2019-2020 | |
| Biogen, INC. | $106.00 | 2019-2020 | |
| Ucb, INC. | $88.57 | 2019-2020 | |
| Amgen INC. | $83.85 | 2019 | |
| Abbvie INC. | $78.17 | 2019-2021 | |
| Adamas Pharmaceuticals, INC. | $78.01 | 2019 | |
| Mallinckrodt Enterprises LLC | $71.72 | 2019 | |
| Acorda Therapeutics, INC | $64.37 | 2019 | |
| Mdd US Operations, LLC | $49.73 | 2019-2020 | |
| Vertical Pharmaceuticals, LLC | $42.29 | 2019-2020 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $39.82 | 2019 | |
| Kyowa Kirin, INC. | $31.98 | 2019-2020 | |
| Tanabe Pharma America, INC. | $28.73 | 2019-2020 | |
| Tersera Therapeutics LLC | $26.02 | 2019 | |
| Alnylam Pharmaceuticals INC. | $24.96 | 2020 | |
| Abbott Laboratories | $23.38 | 2025 | Mitraclip |
| Alexion Pharmaceuticals, INC. | $21.85 | 2019 | |
| Amneal Pharmaceuticals LLC | $21.19 | 2019 | |
| Acadia Pharmaceuticals INC | $20.90 | 2019 | |
| Neurocrine Biosciences, INC. | $18.55 | 2019 | |
| Eisai INC. | $18.50 | 2020 | |
| Lilly USA, LLC | $16.50 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $15.55 | 2019 | |
| Allergan, INC. | $14.38 | 2019 | |
| Biohaven Pharmaceuticals, INC. | $13.25 | 2021 | |
| Neurelis, INC. | $11.41 | 2020 | |
| Harmony Biosciences LLC | $11.17 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Burke listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.